Ocular Therapeutix OCUL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$290.5M-50.7% | -$265.94M-37.4% | -$249.67M-43.2% | -$216.75M-56.7% | -$192.71M-67.2% | ||
| $4.63M+20.2% | $4.32M+14.2% | $4.03M+6.2% | $3.92M+5.2% | $3.85M+12.5% | ||
| $48.31M+35.8% | $43.18M+30.4% | $39.02M+29.0% | $33.97M+20.8% | $35.59M+67.6% | ||
| -$226.21M-55.5% | -$204.88M-52.1% | -$190.06M-61.5% | -$175.9M-97.9% | -$145.46M-72.9% | ||
| $14.74M+397% | $12.01M+832% | $9.37M+507% | $3.47M+102% | $2.97M+0.1% | ||
| -$14.61M-393% | -$11.88M-822% | -$9.24M-498% | -$3.34M-94.7% | -$2.97M-0.1% | ||
| $557.83M+3,602% | $561.72M+69.1% | $116.86M-73.2% | $110.68M-77.1% | $15.07M-96.9% | ||
| $317.02M— | $344.96M— | —— | —— | —— | ||
| -$240.94M-62.3% | -$216.89M-59.5% | -$199.44M-67.2% | -$179.37M-98.0% | -$148.43M-70.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ocular Therapeutix generate?
- Ocular Therapeutix (OCUL) generated -$226.2M in operating cash flow over the trailing twelve months.
- What is Ocular Therapeutix's free cash flow?
- After $14.7M of capital expenditures, Ocular Therapeutix's free cash flow was -$240.9M over the trailing twelve months, down 62.3% year over year.
- Where does Ocular Therapeutix's cash flow data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
